Simplex Trading’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $412K | Sell |
5,722
-16,214
| -74% | -$923K | ﹤0.01% | 3501 |
|
|
2025
Q4 | $927K | Sell |
21,936
-54,514
| -71% | -$3.05M | ﹤0.01% | 2698 |
|
|
2025
Q3 | $4.35M | Buy |
76,450
+29,497
| +63% | +$976K | ﹤0.01% | 1603 |
|
|
2025
Q2 | $1.21M | Buy |
46,953
+24,024
| +105% | +$270K | ﹤0.01% | 2586 |
|
|
2025
Q1 | $233K | Buy |
22,929
+22,084
| +2,613% | +$289K | ﹤0.01% | 4160 |
|
|
2024
Q4 | $11K | Buy |
845
+379
| +81% | +$6.68K | ﹤0.01% | 7133 |
|
|
2024
Q3 | $9K | Buy |
466
+316
| +211% | +$6.02K | ﹤0.01% | 7262 |
|
|
2024
Q2 | $2K | Buy |
+150
| New | +$3.16K | ﹤0.01% | 8314 |
|
|
2024
Q1 | – | Sell |
-255
| Closed | -$2.67K | – | 9517 |
|
|
2023
Q4 | $2K | Sell |
255
-453
| -64% | -$3.43K | ﹤0.01% | 8310 |
|
|
2023
Q3 | $6K | Buy |
708
+234
| +49% | +$2.25K | ﹤0.01% | 7549 |
|
|
2023
Q2 | $4K | Buy |
474
+143
| +43% | +$1.52K | ﹤0.01% | 8068 |
|
|
2023
Q1 | $3K | Sell |
331
-77
| -19% | -$2.33K | ﹤0.01% | 8326 |
|
|
2022
Q4 | $13K | Sell |
408
-879
| -68% | -$42.5K | ﹤0.01% | 7299 |
|
|
2022
Q3 | $61K | Buy |
1,287
+307
| +31% | +$18.3K | ﹤0.01% | 6163 |
|
|
2022
Q2 | $55K | Sell |
980
-280
| -22% | -$17.7K | ﹤0.01% | 6368 |
|
|
2022
Q1 | $101K | Buy |
+1,260
| New | +$186K | ﹤0.01% | 6130 |
|
|
2021
Q4 | – | Sell |
-383
| Closed | -$83.1K | – | 11093 |
|
|
2021
Q3 | $100K | Sell |
383
-53
| -12% | -$12.7K | ﹤0.01% | 6622 |
|
|
2021
Q2 | $112K | Buy |
436
+56
| +15% | +$15.5K | ﹤0.01% | 6558 |
|
|
2021
Q1 | $114K | Buy |
380
+43
| +13% | +$13.4K | ﹤0.01% | 5566 |
|
|
2020
Q4 | $85K | Sell |
337
-1,531
| -82% | -$396K | ﹤0.01% | 5612 |
|
|
2020
Q3 | $464K | Sell |
1,868
-167
| -8% | -$52.5K | ﹤0.01% | 3095 |
|
|
2020
Q2 | $706K | Sell |
2,035
-476
| -19% | -$149K | ﹤0.01% | 2480 |
|
|
2020
Q1 | $672K | Sell |
2,511
-2,888
| -53% | -$893K | ﹤0.01% | 2286 |
|
|
2019
Q4 | $1.75M | Buy |
5,399
+2,149
| +66% | +$623K | ﹤0.01% | 1594 |
|
|
2019
Q3 | $888K | Buy |
3,250
+2,625
| +420% | +$963K | ﹤0.01% | 2044 |
|
|
2019
Q2 | $333K | Sell |
625
-920
| -60% | -$461K | ﹤0.01% | 2963 |
|
|
2019
Q1 | $778K | Buy |
1,545
+646
| +72% | +$383K | ﹤0.01% | 2210 |
|
|
2018
Q4 | $443K | Sell |
899
-1,064
| -54% | -$642K | ﹤0.01% | 2343 |
|
|
2018
Q3 | $1.79M | Sell |
1,963
-229
| -10% | -$195K | 0.01% | 1334 |
|
|
2018
Q2 | $1.6M | Buy |
2,192
+1,008
| +85% | +$1.16M | 0.01% | 1331 |
|
|
2018
Q1 | $1.89M | Buy |
+1,184
| New | +$1.53M | 0.08% | 201 |
|
|
2017
Q4 | – | Sell |
-2,064
| Closed | -$1.22M | – | 6435 |
|
|
2017
Q3 | $743K | Buy |
2,064
+1,843
| +834% | +$577K | 0.03% | 488 |
|
|
2017
Q2 | $64K | Buy |
221
+188
| +570% | +$54.3K | ﹤0.01% | 2162 |
|
|
2017
Q1 | $11K | Sell |
33
-1,521
| -98% | -$342K | ﹤0.01% | 3893 |
|
|
2016
Q4 | $286K | Buy |
1,554
+1,372
| +754% | +$279K | 0.02% | 829 |
|
|
2016
Q3 | $46K | Buy |
182
+113
| +164% | +$29.1K | ﹤0.01% | 2183 |
|
|
2016
Q2 | $14K | Sell |
69
-27
| -28% | -$6.04K | ﹤0.01% | 3249 |
|
|
2016
Q1 | $19K | Buy |
+96
| New | +$18.4K | ﹤0.01% | 2855 |
|
|
2015
Q4 | – | Sell |
-852
| Closed | -$175K | – | 5890 |
|
|
2015
Q3 | $140K | Buy |
+852
| New | +$151K | 0.01% | 1144 |
|
|
2015
Q2 | – | Sell |
-373
| Closed | -$64.2K | – | 5636 |
|
|
2015
Q1 | $61K | Sell |
373
-455
| -55% | -$93.5K | 0.01% | 1417 |
|
|
2014
Q4 | $192K | Buy |
+828
| New | +$177K | 0.02% | 622 |
|
Other funds holding NKTR
BI
TSC
VCM
PM
AC
Simplex Trading's NKTR Position: Q1 2026 in Review
Simplex Trading reduced its Nektar Therapeutics (NKTR) stake by 74% in Q1 2026, selling an estimated $923K and leaving 5,722 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #3501.
Simplex Trading first reported a position in NKTR in Q4 2014 and has held it in 41 quarters since. The position peaked at $4.35M in Q3 2025. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.
- Simplex Trading held 5,722 shares of Nektar Therapeutics worth $412K as of Q1 2026.
- Simplex Trading sold 16,214 Nektar Therapeutics shares in Q1 2026, an estimated $923K.
- Nektar Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3501 holding.
- Simplex Trading first reported a position in Nektar Therapeutics in Q4 2014 and has held it in 41 quarters since.
- Simplex Trading's Nektar Therapeutics position peaked at $4.35M in Q3 2025.
- 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.